Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CME vs GSK✓SelectedUSD · GSKCME vs GSK performance historyLatest closeAs of+0.44%11/16
Stock and ETF performance explorer

CME vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+71.0%
GSK return
+64.4%
Excess return
+6.6%
Maximum drawdown
-31.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-0.1%+0.5%+0.4%
7D+4.9%-1.3%+6.2%+5.0%
30D+8.7%+2.7%+5.9%+8.4%
3M+18.9%+2.7%+16.2%+18.5%
6M+7.9%+3.3%+4.6%+7.5%
YTD+20.9%+6.5%+14.5%+19.6%
1Y+16.4%+10.7%+5.7%+14.6%
3Y+71.0%+64.4%+6.7%+53.6%
All+71.0%+64.4%+6.6%+53.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling